Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Medicine (Baltimore). 2010 Nov;89(6):381–402. doi: 10.1097/MD.0b013e3181fdd832

TABLE 1.

Genetic and Clinical Features of Patients With IL-12Rβ1 Deficiency

Patient Kindred Code Country of Origin* Mutation Age/Sex (yr) Follow-Up Outcome BCG EM Mtb§ Salmonella Candida** Other Diseases†† Ref.
1 1 II.2 Morocco K305X 29.3/F Alive nk - - Stm na na 9,11,44
2 2 II.1 Morocco R213W 28.0/F Alive R - Mtb - na na 3,11
3 2 II.3 Morocco R213W 16.6/M Alive nk - - Sen na na 3,11
4 3 II.3 Cameroon Y367C 8.2/M Alive D - - Sd, Sh - - 11
5 4 II.1 Cyprus 1623_1624delinsTT 39.0/M Alive R Ma, Mt, Mg - - - 9,11,33,37
6 4 II.2 Cyprus NA 7.5/M Deceased R Ma - - Ca - 9,11,33,37
7 4 II.3 Cyprus 1623_1624delinsTT 27.1/F Alive R - - S. spp - - 9,11,33,37
8 5 II.3 Turkey (Kurds) 783+1G>A 21.8/F Alive D - - - - - 9,11,32
9 5 II.4 Turkey (Kurds) 783+1G>A 17.4/M Alive nv - - - - - 9,11,32
10 6 II.2 Turkey (Kurds) 783+1G>A 20.3/F Alive D - - Se - - 11
11 6 II.3 Turkey (Kurds) 783+1G>A 15.0/M Alive D - - - - - 11
12 7 II.5 Turkey R173P 17.4/M Deceased R Ma, Mfc Mtb - Ca - 11,14
13 8 II.2 Turkey R173P 14.8/F Alive L Mc - Se - Leukocytoclastic vasculitis 11,25
14 9 II.3 Turkey 557_563delins8 18.0/F Alive L - - Se, Stm, St Ca Vasculitis 11
15 10 II.2 Israel (Bedouin Arab) 700+362_1619-944del 9.9/M Alive nv - - SD Ca - 11,18,19,44
16 11 II.2 KSA 1190-1G>A 8.4/F Alive D - - - - - 11
17 12 II.2 Qatar C186S 13.0/F Alive L - - Se - - 11
18 12 II.6 Qatar C186S 3.4/M Deceased D - - - - - -
19 13 II.5 Qatar C186S 10.6/F Alive R M. spp - SD - - 11
20 13 II.7 Qatar C186S 9.1/M Alive R M. spp - S. spp - - 11
21 14 II.2 Iran 1791+2T>G 13.5/M Alive nv - - Se - - 11,16
22 15 II.2 Pakistan S321X 24.2/M Alive R - - Se - - 11
23 16 II.1 Sri Lanka 1791+2T>G 23.9/F Alive D - - - - - 11
24 17 II.1 France [Q32X]+[1623_1624delinsT] 18.8/M Alive R - - - na na 11
25 17 II.2 France [Q32X]+[1623_1624delinsT] 13.8/M Alive nv Mg - Stm na na 11
26 18 II.1 France Q376X 30.8/M Alive R - - Sd Ca - 11
27 19 II.1 France [1745 1746delinsCA]+[1483+182_1619-1073del] 37.2/F Alive nk - - S. spp, Sd Ca Toxoplasma retinitis 11,44
28 20 II.1 France Q32X 11.7/F Alive nk - - - na na 11,44
29 21 II.1 Belgium Q32X 21.5/F Alive nv - - - na na 11,44
30 21 II.2 Belgium Q32X 7.2/F Deceased nv Ma - Se Ca - 11,34
31 22 II.1 Germany 1623_1624delinsTT 3.5/M Deceased nv Ma - - na na 11
32 23 II.1 Germany 1623_1624delinsTT 14.9/F Alive D - - Se - - 11
33 23 II.2 Germany 1623_1624delinsTT 11.9/F Alive nv - - S. spp - - 11
34 24 II.1 Spain 1791+2T>G 21.5/F Alive nv - - - - - 5,11
35 24 II.2 Spain 1791+2T>G 11.5/F Alive nv - Mtb - - - 5,11
36 24 II.3 Spain 1791+2T>G 18.9/F Alive nv - Mtb Se - - 5,11
37 25 II.1 Spain 1791+2T>G 7.5/F Deceased nv Ma - Se Ca - 11
38 26 II.1 Bosnia and Herzegovina NA 3.8/M Deceased D - - - - - 11
39 26 II.4 Bosnia and Herzegovina 549+2T>C 12.0/F Alive nv M. spp - - - - 11
40 27 II.2 Slovakia [1440_1447delins16]+[Q171P] 2.4/F Deceased D - - - - - 11,20
41 28 II.3 Slovakia [1007_1008delinsG]+[Q171P] 9.0/F Alive D - - - - - 11,20
42 29 II.1 Brazil L77P 29.8/M Alive L - - Stm - Paracoccidioides brasiliensis, Toxoplasma gondii chorioretinitis 11,21
43 30 II.5 Spain NA 6.9/M Deceased na - - Se Ca - -
44 30 II.6 Spain 1791+2T>G 30.2/M Deceased nv - - Se, Sp Ca Esophageal carcinoma -
45 31 II.6 Mexico NA na/M Deceased na - - S. spp - - -
46 31 II.8 Mexico 1791+2T>G 34.0/M Alive R - - SB - - -
47 32 II.2 Belgium [1623_1624delinsTT]+[65delCTGC] 13.7/F Deceased nv Ma - - - - 46,49
48 33 II.1 France [C196Y]+[1483+182_1619-1073del] 27.8/F Alive R - - Stm na na 31
49 34 II.2 Poland [I369T]+[1623_1624delinsTT] 5.9/F Deceased D - - - - - -
50 35 II.3 KSA Y88X 12.1/M Alive D - - SD - - -
51 35 II.4 KSA Y88X 6.1/F Alive D - - SD - Citrobacter freundii -
52 36 II.6 Qatar C186S 8.5/F Alive R - - SD - Ataxia-telangiectasia 48
53 37 II.1 Turkey R173P 14.3/M Alive R - - Se - - 44
54 38 II.2 Turkey 711insC 2.0/F Deceased D - - - Ca - 26
55 39 II.1 Turkey 628-644dup 10.7/M Alive L - - S. spp - - -
56 39 II.2 Turkey 628-644dup 4.9/M Deceased L Ma - S. spp Ca - 26
57 39 II.5 Turkey 628-644dup 2.5/M Alive L - - - Ca - -
58 40 II.2 KSA 1336delC 7.8/M Alive L - - - - - -
59 40 II.3 KSA 1336delC 3.8/F Deceased D - - - - - -
60 41 II.2 Turkey 783+1G>A 3.1/M Deceased R - - Se Ca - 26
61 42 II.1 Israel (Arabic) 700+362_1619-944del 11.5/F Alive nv - - - - - -
62 42 II.2 Israel (Arabic) 700+362_1619-944del 9.4/M Deceased nv Ma - Stm - - 29
63 42 II.3 Israel (Arabic) 700+362_1619-944del 2.1/F Deceased nv Ma - - - - -
64 43 II.1 Turkey R486X 4.0/M Alive L - - - - - 50
65 44 II.1 Mexico 1791+2T>G 3.6/F Deceased D - - - Ca - -
66 44 II.2 Mexico 1791+2T>G 2.2/M Alive nv - - - - - -
67 44 II.3 Mexico 1791+2T>G 8 mo/F Alive nv - - - - - -
68 45 II.4 Iran 1791+2T>G 8.6/F Alive D - - - - - -
69 46 I.2 Iran 580+1G>A na/F Alive na - - - na na -
70 46 II.2 Iran 580+1G>A 4.1/M Alive D - - - - - -
71 47 II.1 Brazil [983_999del] + [R173W] 5.8/F Alive D - - - - - -
72 48 II.1 KSA Y88X 3.4/F Alive D - - - - - -
49 II.1 Turkey 783+1G>A 1.9/M Deceased D - - - Ca - -
74 50 II.1 Brazil 1791+2T>G 2.0/M Deceased D - - - - - 36
75 51 II.2 KSA Y88X 5.1/M Alive D Ms - - - - -
76 52 II.3 Venezuela R173W 13.7/M Deceased R - - Se Ca - -
77 53 II.2 Ukraine [1189+2T>A]+[1791+2T>G] 9.1/M Alive D M. spp - Stm, Se - - -
78 54 II.1 India R521X 8.5/F Alive D - Mtb - - Histoplasmosis -
79 55 II.1 Taiwan R211P 23.5/M Alive R - - Se - - 22,47
80 56 II.1 Poland R173W 16.6/F Alive D - - Se - - -
81 57 II.1 Mexico 1791+2T>G 16.5/M Deceased D - - - Ca - -
82 57 II.5 Mexico 1791+2T>G 3.3/M Deceased D - - - - - -
83 58 II.1 China NA 1.2/M Deceased D - - - - - 30
84 58 II.2 China 1791+2T>G 3.8/F Alive D - - - - - 30
85 59 II.1 Chile [169delA]+[C62G] 2.1/M Deceased D - - - - - -
86 60 II.1 Turkey C198R 7.9/F Alive R - - - - - -
87 60 II.2 Turkey C198R 3.7/M Alive L - - Stm - - -
88 61 II.1 China NA 10.6/M Deceased nv - Mtb - - - 30
89 61 II.2 China Q285X 2.0/F Deceased D - - - - - 30
90 62 II.1 Iran R521X 7.5/M Alive D - - - - - -
91 63 II.2 KSA 1190-1G>A 13.1/M Alive D - - Stm - - 44
92 63 II.4 KSA 1190-1G>A 9.1/M Alive R - - SD - - 44
93 64 II.2 Netherlands Q376X 28.4/F Deceased nv Ma - Stm Ca - 10,37
94 65 II.1 Argentina [E67X]+[1623_1624delinsTT] 3.1/M Alive D - - - - - 49
95 66 II.1 UK 1623_1624delinsTT 6.8/F Deceased nv MAIc - - - Klebsiella pneumoniae -
96 67 II.1 Ukraine E480X 11.6/M Alive L - - Stm - - -
97 67 II.2 Ukraine E480X 2.7/M Alive D - - Stm - - -
98 68 II.3 Turkey NA 4.4/F Deceased D - - - na - -
99 68 II.4 Turkey NA 5.0/F Deceased D - - - na - -
100 68 II.6 Turkey R175W 2.6/M Alive L - - - - - -
101 69 II.1 Turkey R175W 6.0/F Alive R - - Se - - 27
102 70 II.1 French West Indies 1765delG 32.0/M Alive M. spp M. spp M. spp SD - - -
103 71 II.1 Turkey 467_483del 5.0/M Deceased D - - - - - 17
104 71 II.2 Turkey 467_483del 8.0/M Alive nv - - SD - Leishmania 17,23,28
105 72 II.2 Turkey C198R 15.7/M Alive D - - - - - 17
106 73 II.1 Turkey 783+1G>A 4.0/M Deceased D - - - Ca - 17
107 73 II.2 Turkey 783+1G>A 10.2/F Alive nv M. spp M. spp SB, SD Ca Leukocytoclastic vasculitis 17
108 74 II.1 Turkey NA 4.2/F Deceased D - - - - - 35
109 74 II.2 Turkey 783+1G>A 11.1/M Alive nv - - SD - - 23
110 75 II.1 Turkey 783+1G>A 7.0/F Deceased D - - - Ca - 17
111 75 II.2 Turkey 783+1G>A 4.0/M Deceased D - - - Ca - 17
112 76 II.1 Turkey 783+1G>A 6.4/F Alive L - - - - - -
113 77 II.1 Turkey R173P 16.8/M Alive L - - Se, St, Spt - - 23
114 78 II.2 Mexico R486X 4.7/M Deceased D - - S. spp Ca K. pneumoniae -
115 79 II.5 KSA Y88X 5.7/F Alive R - - SB - Klebsiella spp. -
116 79 II.6 KSA Y88X 1.3/M Alive L - - - - - -
117 80 II.7 Qatar C186S 1.6/F Alive D - - - - - -
118 81 II.1 Turkey 64+2T>G 4.2/M Alive D - - - Ca - -
119 82 II.5 Turkey 1425delC 3.0/M Alive D - - Se Ca - -
120 83 II.1 Turkey 783+1G>A 3.9/M Alive D - - - Ca - -
121 84 II.3 Iran G569D 5.5/F Alive D - Mtb - - - -
122 85 II.4 Iran T355del 32.4/M Alive R - Mtb - - - -
123 86 II.1 KSA 1791+2T>G 2.0/F Alive D - - - - - -
124 87 II.1 Turkey 64+2T>G 1.7/M Alive L - - - - - -
125 88 II.1 UK Q32X 46.4/F Alive R - - - - - -
126 89 II.1 Turkey 1791+2T>G 3.9/F Alive L - - - Ca -
127 89 II.2 Turkey 1791+2T>G 1.4/F Alive nv - - - - Nocardia nova and K. pneumoniae -
128 90 II.1 Argentina 1623_1624delinsTT 4.6/M Alive D - - - - - 49
129 91 II.2 Argentina W531X 10.3/F Alive D - - - - - -
130 92 II.1 Argentina [1623 1624delinsTT]+[DelEx4] 8.2/F Alive D - - - - - 49
131 93 II.3 Argentina 1623_1624delinsTT 19.8/M Alive D - - - - - 24,49
132 94 II.2 Japan R213W 37.7/M Deceased R Ma - - - - 13
133 95 II.4 Tunisia 64+2T>G 10.9/M Alive D - - - Ca - -
134 96 II.1 Tunisia 1386_1387delGT 6 mo/F Deceased D - - - Ca - -
135 96 II.2 Tunisia 1386_1387delGT 6 mo/M Alive D - - - - - -
136 97 II.1 Tunisia NA 27.6/M Alive R M. spp - - Ca - -
137 98 II.1 Tunisia 550-2A>G 7.8/F Deceased D - - S. spp - K. pneumoniae 15
138 99 II.1 Tunisia 64+5G>A 2.5/M Alive D - - - Ca - 15
139 100 II.1 Argentina [1623_1624delinsTT]+[nk] 7 mo/M Alive D - - - - - -
140 101 II.2 Turkey 1021+1G>C 15.0/F Alive R - Mtb S. spp - - 6
141 102 II.1 China [I369T]+[R211P] 3.1/M Alive D - - - na na -

Abbreviations: KSA = Kingdom of Saudi Arabia, UK = United Kingdom.

*

Ethnicity is in parentheses where relevant.

BCG = Bacille Calmette-Guérin, D = disseminated, L = localized, R = resistant, na = information concerning type of BCG disease is not available, nk = information concerning BCG vaccination is not known, nv = not vaccinated, M. spp = patient had mycobacterial infection without identification of species.

EM = Environmental mycobacteria (nontuberculous mycobacteria), Ma = Mycobacterium avium, M. spp = patient had mycobacterial infection without identification of species, Mt = M. triplex, Mg = M. genevense, Mfc = M. fortuitum-chelonae complex, Mc = M. chelonae, Ms = M. simiae, MAIc = M. avium intracellulare complex.

§

Mtb = M. tuberculosis, M. spp = patient had mycobacterial infection without identification of species.

Stm = Salmonella typhimurium, Sen = S. enteritica, Sd = S. dublin, Sh = S. hadar, Se = S. enteritidis, Sp = S. Portland, SB = S. group B, SD = S. group D, St = S. typhi, Spt = S. paratyphi, S. spp = patient had salmonellosis without identification of species.

**

Ca = Candida albicans, na = information on whether patient had candidiasis is not available.

††

na = Information on whether patient had other diseases is not available.